Radiography
Volume 13 , Pages e85-e89 , December 2007

MR angiography with Vasovist®

Received 4 December 2006 ,Revised 26 April 2007 ,Accepted 30 April 2007.

References 

  1. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–515
  2. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol. 1992;45:529–542
  3. Rieker O, Duber C, Neufang A, Pitton M, Schweden F, Thelen M. CT angiography versus intraarterial digital subtraction angiography for assessment of aortoiliac occlusive disease. AJR. 1997;169:1133–1138
  4. Tan KT, van Beek EJ, Brown PW, van Delden OM, Tijssen J, Ramsay LE. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol. 2002;57:617–624
  5. Grist T. MRA of the abdominal aorta and lower extremities. JMRI. 2000;11:32–43
  6. Prince MR, Meaney JF. Expanding role of MR angiography in clinical practice. Eur Radiol. 2006;(16 Suppl. 2):B3–B8
  7. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology. 1995;197(3):785–792
  8. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of Vasovist®-enhanced MR angiography—multicenter comparative phase III study. Radiology. 2005;236:71–78
  9. Goyen M, Edelman M, Perreault P, et al. MR Angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology. 2005;236:825–833
  10. Shamsi K, Yucel EK, Chamberlin P. A Summary of safety of gadofosveset (MS-325) at 0.03mmol/kg body weight dose: phase II and phase III clinical trials data. Invest Radiol. 2006;41:822–830
  11. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674–682
  12. Schoenberg SO, Rieger JR, Weber CH, et al. High-spatial-resolution MR-angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Radiology. 2005;236:687–698
  13. Schoenberg SO, Bock M, Knopp MV, et al. Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing-independent fast multiphase acquisition in a single breath hold. Radiology. 1999;211:667–679
  14. Meissner OA, Rieger J, Weber C, et al. Critical Limb Ischemia: hybrid-MR angiography compared with DSA. Radiology. 2005;235:308–318
  15. Nikolaou K, Kramer H, Grosse C, et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology. 2006 Oct 10;[Epub ahead of print]
  16. Herborn CU, Ajaj W, Goyen M, Massing S, Ruehm SG, Debatin JF. Peripheral vasculature: whole-body MR angiography with midfemoral venous compression—initial experience. Radiology. 2004;230:872–878
  17. Kramer H, Schoenberg SO, Nikolaou K, et al. Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology. 2005;236:300–310
  18. Ruehm SG, Wiesner W, Debatin JF. Pelvic and lower extremity veins: contrast-enhanced three-dimensional MR venography with a dedicated vascular coil-initial experience. Radiology. 2000;215:421–427
  19. Oudkerk M, van Beek EJ, Wielopolski P. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet. 2002;359:1643–1647

PII: S1078-8174(07)00040-5

doi: 10.1016/j.radi.2007.04.002

Radiography
Volume 13 , Pages e85-e89 , December 2007

Article Tools

* Image Usage & Resolution